Although not yet completed, cardiovascular outcomes of tirzepatide will likely be similar to GLP-1 RAs based on the mechanism of the drug
High medication costs remain a significant barrier, with the average price of GLP-1 drugs reaching USD 1,200 per month, making them inaccessible to many
The Allergan acquisition was, in part, a hedge against the Humira cliff: by the time biosimilars arrived, AbbVie had substantial revenue from non-adalimumab sources
Cells were seeded into a 384-well glass-bottom black plate (IBL, P384-1.5H-N) and left to adhere overnight
Sa1950 impact of GLP1 agonists on inflammatory biomarkers in patients with inflammatory bowel disease
References: A Brave New World: Therapeutic Area Deep Dives on Obesity Related solutions Grow your brand, now and through patent expiry Data, AI, and expertise empower Commercial Solutions to optimize strategy, accelerate market access, and maximize brand performance